Abstract #0077

CEST-MRI guided sequential drug delivery using injectable hydrogel for local treatment in the brain

Xiongqi Han¹, Jianpan Huang¹, and Kannie Wai Yan Chan^1,2,3

¹Biomedical Engineering, City University of Hong Kong, Hong Kong, Hong Kong, ²Biomedical Engineering, Shenzhen Research Institute, City University of Hong Kong, Shenzhen, China, ³Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, United States

Glioblastoma (GBM) is the most malignant brain tumor with notorious heterogeneous, infiltrative and chemoresistance. Here, we developed a hydrogel-based drug delivery system for sequential and sustainable local drug delivery with rheological properties that favor applications to the brain. We designed methotrexate (MTX) to release prior to gemcitabine (Gem). Using CEST, the multicomponent of hydrogel matrix could be detected at 3 T, including the contrast of loaded drugs (5.4%) at 2.2-2.4 ppm and liposomal hydrogel matrix at -3.6 ppm in vitro. Furthermore, it showed combined cytotoxicity on U87 cells, demonstrating its potential on CEST MRI guided local treatment.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.